1. Home
  2. HBIO vs LTRN Comparison

HBIO vs LTRN Comparison

Compare HBIO & LTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harvard Bioscience Inc.

HBIO

Harvard Bioscience Inc.

HOLD

Current Price

$6.69

Market Cap

25.7M

Sector

Industrials

ML Signal

HOLD

Logo Lantern Pharma Inc.

LTRN

Lantern Pharma Inc.

HOLD

Current Price

$2.46

Market Cap

22.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HBIO
LTRN
Founded
1901
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
25.7M
22.2M
IPO Year
2000
2020

Fundamental Metrics

Financial Performance
Metric
HBIO
LTRN
Price
$6.69
$2.46
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$18.00
N/A
AVG Volume (30 Days)
72.3K
1.3M
Earning Date
05-11-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
18.65
EPS
N/A
N/A
Revenue
$116,176,000.00
N/A
Revenue This Year
$4.77
N/A
Revenue Next Year
$8.55
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.28
$1.11
52 Week High
$7.00
$5.74

Technical Indicators

Market Signals
Indicator
HBIO
LTRN
Relative Strength Index (RSI) 70.00 55.07
Support Level $0.47 $1.11
Resistance Level N/A $3.79
Average True Range (ATR) 0.52 0.30
MACD 0.02 0.08
Stochastic Oscillator 90.85 73.46

Price Performance

Historical Comparison
HBIO
LTRN

About HBIO Harvard Bioscience Inc.

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.

About LTRN Lantern Pharma Inc.

Lantern Pharma Inc is a biopharmaceutical company focused on developing oncology drug candidates using its artificial intelligence platform. The company utilizes its proprietary RADR platform to identify, develop, and advance small molecule therapies and antibody-drug conjugates, with a pipeline that includes three lead small molecule drug candidates (LP-300, LP-184, and LP-284) targeting solid tumors and blood cancers. It also advances programs through its subsidiary focused on central nervous system and brain cancers.

Share on Social Networks: